AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Johnson & Johnson Pharmaceutical Research & Development Submits New Drug Application for Paliperidone Palmitate.
TITUSVILLE, N.J., Oct. 29 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for paliperidone palmitate, an investigational, once-monthly atypical antipsychotic intramuscular injection, for the treatment of schizophrenia and the prevention of recurrence of the symptoms of schizophrenia.
Paliperidone palmitate is a long-acting injectable ester of the active ingredient in INVEGA(TM)(1) which utilizes Elan's NanoCrystal(R) Technology. Upon approval, paliperidone palmitate will be marketed in the U.S. by Janssen, L.P.
Worldwide, it is estimated that one person in every 100 develops schizophrenia, one of the most serious types of mental illness. In the United States, there are currently 2,000,000 people with schizophrenia, with men and women affected equally. The disease is marked by positive symptoms (hallucinations and delusions) and negative symptoms (depression, blunted emotions, and social withdrawal), as well as by disorganized thinking.
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD) is headquartered in Raritan, New Jersey (USA), and has nine sites throughout Europe and the United States. J&JPRD employs…
- J&J's Invega wins FDA approval.(RX RETAIL PHARMACY: Branded Drugs)(Johnson &...
- Magazine article from: Chain Drug Review January 22, 2007 700+ words
...WASHINGTON -- The Food and Drug Administration has approved Invega, Johnson & Johnson's next-generation schizophrenia pill...possibility of a life-threatening heart disorder. Invega is formulated to deliver paliperidone (the active ingredient...
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA...
- Newspaper article from: Blood Weekly February 19, 2009 700+ words
...schizoaffective disorder (see also Johnson & Johnson Pharmaceutical Research...approval for the use of INVEGA tablets for the treatment...respectively.(i) INVEGA, an atypical antipsychotic...paliperidone palmitate. Johnson & Johnson Pharmaceutical...
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Announces FDA...
- Press release article from: PR Newswire February 6, 2009 700+ words
...6 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research...approval for the use of INVEGA tablets for the treatment...respectively.(i) INVEGA, an atypical antipsychotic...paliperidone palmitate. Johnson & Johnson Pharmaceutical...
- Johnson & Johnson Pharmaceutical Research & Development L L C announces FDA...
- News wire article from: Chemical Business Newsbase February 6, 2009 700+ words
...requesting approval for the use of INVEGA tablets for the treatment of...the efficacy and safety of INVEGA in patients with schizoaffective...If approved by the FDA, INVEGA would be the only medication...amp;JPRD is a subsidiary of Johnson & Johnson, the world...
- INVEGA(TM) Shows Favorable Long-Term Safety Profile in a One-Year Study of...
- Press release article from: PR Newswire December 12, 2007 700+ words
...LLC, Johnson & Johnson Pharmaceutical Research...company that markets INVEGA. The study consisted...LLC and Johnson & Johnson Pharmaceutical Research...Janssen, L.P., markets INVEGA in the U.S. Each of...companies is a subsidiary of Johnson & Johnson. ...
- INVEGA(TM) Receives Marketing Authorization In European Union For Treatment Of...
- Press release article from: PR Newswire June 28, 2007 700+ words
...by disorganized thinking. INVEGA was approved in the U.S...since 2003. In April 2007, INVEGA was also approved by the FDA...treatment of schizophrenia. INVEGA was discovered and jointly developed by ALZA Corporation and Johnson & Johnson Pharmaceutical...
- FDA Approves INVEGA (TM) for Long-Term Maintenance Treatment of Schizophrenia.
- Press release article from: PR Newswire April 27, 2007 700+ words
...Administration (FDA) today approved INVEGA(TM) (paliperidone) Extended...by disorganized thinking. INVEGA was approved in December 2006...and tolerability profile. INVEGA was discovered and jointly...by Janssen, ALZA Corp. and Johnson & Johnson Pharmaceutical...
- Study Suggests INVEGA(TM) Helps Patients With Schizophrenia Maintain Symptom...
- Press release article from: PR Newswire March 30, 2007 700+ words
...Longer-term treatment with INVEGA(TM) (paliperidone) Extended...the U.S. marketer of INVEGA, and were presented today...Schizophrenia Research (ICOSR). INVEGA was approved last December...Meltzer, MD, Bixler/May/Johnson Professor of Psychiatry &...
- Janssen, L.P. Selects INVEGA(TM) (paliperidone) Extended Release tablets as...
- Press release article from: PR Newswire November 10, 2006 700+ words
...wholly owned subsidiary of Johnson & Johnson, announced that it has selected INVEGA(TM) as the brand name...two month) review for INVEGA(TM). The new user fee...now December 20, 2006. Johnson & Johnson Pharmaceutical...
- INVEGA(R) Receives Positive Opinion From European Committee for Human Medicinal...
- Press release article from: PR Newswire April 27, 2007 700+ words
...benefits when considering taking INVEGA(R). Worldwide, it is estimated...release tablets was developed by Johnson & Johnson Pharmaceutical Research and Development (J&JPRD). INVEGA(TM) has been approved by the...
Source: HighBeam Research, Johnson & Johnson Pharmaceutical Research & Development Submits New...
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA
The AccessMyLibrary advertising network includes:
